BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26317246)

  • 1. Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population.
    Fratelli M; Bolis M; Kurosaki M; Dori M; Guarnaccia V; Spinelli O; Alberti M; Valoti E; Pileggi S; Noris M; Remuzzi G; Rambaldi A; Terao M; Garattini E
    Leuk Lymphoma; 2016 May; 57(5):1234-7. PubMed ID: 26317246
    [No Abstract]   [Full Text] [Related]  

  • 2. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
    Dragon-Durey MA; Blanc C; Marliot F; Loirat C; Blouin J; Sautes-Fridman C; Fridman WH; Frémeaux-Bacchi V
    J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
    PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.
    Holmes LV; Strain L; Staniforth SJ; Moore I; Marchbank K; Kavanagh D; Goodship JA; Cordell HJ; Goodship TH
    PLoS One; 2013; 8(4):e60352. PubMed ID: 23613724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2008 Apr; 17(7):971-7. PubMed ID: 18084039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
    Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia.
    Maung KZY; Leo PJ; Bassal M; Casolari DA; Gray JX; Bray SC; Pederson S; Singhal D; Samaraweera SE; Nguyen T; Cildir G; Marshall M; Ewing A; Duncan EL; Brown MA; Saal R; Tergaonkar V; To LB; Marlton P; Gill D; Lewis I; Deans AJ; Brown AL; D'Andrea RJ; Gonda TJ
    Blood Cancer J; 2018 Jun; 8(6):50. PubMed ID: 29891941
    [No Abstract]   [Full Text] [Related]  

  • 9. The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases.
    Hamza A; El-Sissy C; Yousfi N; Martins PV; Rafat C; Masliah-Planchon J; Frémeaux-Bacchi V; Mesnard L
    Eur J Hum Genet; 2023 Jul; 31(7):730-732. PubMed ID: 37032353
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.
    Schmid-Kubista KE; Tosakulwong N; Wu Y; Ryu E; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5070-9. PubMed ID: 19553609
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sadigh S; Morrissette JJD; Bagg A
    Leuk Lymphoma; 2019 Jun; 60(6):1601-1602. PubMed ID: 30632836
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and functional analysis of acute myeloid leukemia susceptibility associated single nucleotide polymorphisms at non-protein coding regions of RUNX1.
    Xu X; Ren X; Wang H; Zhao Y; Yi Z; Wang K; Zhang S; Wang L; Samuelson DJ; Hu Z
    Leuk Lymphoma; 2016; 57(6):1442-9. PubMed ID: 26374622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3).
    Koziolek MJ; Zipfel PF; Skerka C; Vasko R; Gröne EF; Müller GA; Strutz F
    Kidney Int; 2008 Aug; 74(3):384-8. PubMed ID: 18449173
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes.
    Bhasym A; Gurjar BS; Prabhu S; Puraswani M; Khandelwal P; Saini H; Saini S; Chatterjee P; Bal V; George A; Coshic P; Patidar G; Hari P; Sinha A; Bagga A; Rath S; Guchhait P
    J Clin Immunol; 2019 Apr; 39(3):336-345. PubMed ID: 30945073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the CFHR1 level and its genetic polymorphisms in type 2 diabetes mellitus patients].
    Wang J; Yu W; Xu J; Feng L; Liu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):438-442. PubMed ID: 28604974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.
    Schejbel L; Schmidt IM; Kirchhoff M; Andersen CB; Marquart HV; Zipfel P; Garred P
    Genes Immun; 2011 Mar; 12(2):90-9. PubMed ID: 21270828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
    Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
    Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia.
    Wouters BJ; Sanders MA; Lugthart S; Geertsma-Kleinekoort WM; van Drunen E; Beverloo HB; Löwenberg B; Valk PJ; Delwel R
    Leukemia; 2007 Nov; 21(11):2382-4. PubMed ID: 17554374
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease.
    Irmscher S; Zipfel SLH; Halder LD; Ivanov L; Gonzalez-Delgado A; Waldeyer C; Seiffert M; Brunner FJ; von der Heide M; Löschmann I; Wulf S; Czamara D; Papac-Milicevic N; Strauß O; Lorkowski S; Reichenspurner H; Holers MV; Banda NK; Zeller T; Binder EB; Binder CJ; Wiech T; Zipfel PF; Skerka C
    Sci Rep; 2021 Nov; 11(1):22511. PubMed ID: 34795372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.